The SONATA Clinical Trial

 

Women were surveyed 12 months after their Sonata Treatment and reported the following results:

  • 97% would recommend Sonata treatment to a friend
  • 95% reported a reduction in menstrual bleeding
  • 50% returned to normal activity the next day

 

97% would recommend Sonata treatment to a friend at 12 months

95% had a reduction in menstrual bleeding at 12 months

50% returned to normal activity the next day

 

 

Reference: Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal JG. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas: The SONATA Trial. Obstet Gynecol. 2019 Jan; 133(1): 13-22